CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO and President acquired 51,300 shares (grant or award)
- 4 Grant or award VP, Controller acquired 5,900 shares (grant or award)
- 4 Grant or award Chf Scientific Operations Off acquired 19,900 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,700 shares (grant or award)
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 5,225 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 5,855 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,876 shares (to pay taxes)
- 4 Shares withheld for taxes Chf Scientific Operations Off gave up 2,159 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 6,604 shares (to pay taxes)
- 4 Shares withheld for taxes VP, Controller gave up 361 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 15,473 shares at $2.71 ($41,949)
- 4 Open-market buy 10% owner bought 23,900 shares at an average $3.93 ($93,808)
- 4 Open-market buy CEO and President bought 9,065 shares at $3.84 ($34,810)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,081 shares (to pay taxes)
- 4 Grant or award VP, Controller acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Medical Officer gave up 682 shares (to pay taxes)
Page 6 of 20 · 382 filings